Company Filing History:
Years Active: 2013-2015
Title: Innovations of Ching-Shui Huang in Breast Cancer Research
Introduction
Ching-Shui Huang is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of cancer research, particularly in understanding the mechanisms of breast cancer related to nicotine exposure. With a total of 2 patents, his work focuses on innovative methods to combat breast cancer.
Latest Patents
Huang's latest patents include a method for identifying candidate compounds that may inhibit α9-nAChR overexpression or estrogen receptor-dependent transcription in nicotine-derived-compound-induced breast cancer cells. This invention outlines methods for identifying compounds that can inhibit the proliferation of breast cancer cells by targeting the α9-nAChR and its interaction with estrogen receptors. Another significant patent involves the development of small interfering RNAs (siRNAs) aimed at inhibiting the expression of α9-nAChR, which is associated with tumorigenesis in breast cancer. This invention provides methods for the prevention, inhibition, and treatment of malignant progression in breast cancer.
Career Highlights
Ching-Shui Huang is affiliated with Taipei Medical University, where he conducts his research and develops his innovative solutions. His work has garnered attention for its potential impact on breast cancer treatment and prevention.
Collaborations
Huang collaborates with esteemed colleagues, including Chia-Hwa Lee and Ching-Shyang Chen, who contribute to his research efforts and innovations in the field.
Conclusion
Ching-Shui Huang's contributions to breast cancer research through his innovative patents highlight the importance of targeted therapies in combating this disease. His work continues to pave the way for advancements in cancer treatment and prevention.